Arbutus Biopharma Corp (ABUS)
2.715
+0.04
(+1.31%)
USD |
NASDAQ |
May 03, 16:00
2.715
0.00 (0.00%)
After-Hours: 19:18
Arbutus Biopharma Market Cap: 489.17M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 02, 2024 | 482.87M |
May 01, 2024 | 484.67M |
April 30, 2024 | 491.88M |
April 29, 2024 | 500.89M |
April 26, 2024 | 491.88M |
April 25, 2024 | 490.08M |
April 24, 2024 | 495.48M |
April 23, 2024 | 495.48M |
April 22, 2024 | 475.66M |
April 19, 2024 | 490.08M |
April 18, 2024 | 491.88M |
April 17, 2024 | 500.89M |
April 16, 2024 | 526.11M |
April 15, 2024 | 535.12M |
April 12, 2024 | 524.31M |
April 11, 2024 | 545.93M |
April 10, 2024 | 536.92M |
April 09, 2024 | 541.43M |
April 08, 2024 | 556.74M |
April 05, 2024 | 562.15M |
April 04, 2024 | 540.52M |
April 03, 2024 | 526.11M |
April 02, 2024 | 454.04M |
April 01, 2024 | 461.25M |
March 28, 2024 | 464.85M |
Date | Value |
---|---|
March 27, 2024 | 468.45M |
March 26, 2024 | 448.64M |
March 25, 2024 | 448.64M |
March 22, 2024 | 448.73M |
March 21, 2024 | 457.71M |
March 20, 2024 | 457.71M |
March 19, 2024 | 448.73M |
March 18, 2024 | 455.91M |
March 15, 2024 | 470.27M |
March 14, 2024 | 468.47M |
March 13, 2024 | 484.63M |
March 12, 2024 | 482.83M |
March 11, 2024 | 488.22M |
March 08, 2024 | 490.01M |
March 07, 2024 | 484.63M |
March 06, 2024 | 491.81M |
March 05, 2024 | 479.24M |
March 04, 2024 | 486.42M |
March 01, 2024 | 500.78M |
February 29, 2024 | 475.63M |
February 28, 2024 | 489.22M |
February 27, 2024 | 496.01M |
February 26, 2024 | 496.01M |
February 23, 2024 | 496.01M |
February 22, 2024 | 494.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
49.46M
Minimum
Oct 09 2019
628.96M
Maximum
Dec 01 2021
317.75M
Average
340.14M
Median
Aug 08 2023
Market Cap Benchmarks
Moderna Inc | 47.85B |
Pacira BioSciences Inc | 1.266B |
Chimerix Inc | 85.18M |
Karyopharm Therapeutics Inc | 128.88M |
Corvus Pharmaceuticals Inc | 95.63M |
Market Cap Related Metrics
PS Ratio | 24.84 |
Price to Book Value | 4.614 |
Price | 2.715 |
Earnings Yield | -16.21% |